Phio pharmaceuticals corp phio
WebbOver the last 12 months, Phio Pharmaceuticals's shares have ranged in value from as little as $3.9 up to $29.04. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phio Pharmaceuticals's is 1.4718. Webb31 mars 2024 · Get Phio Pharmaceuticals Corp (PHIO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Phio pharmaceuticals corp phio
Did you know?
WebbPhio is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology is designed to make immune cells more effective in killing tumor cells. Webb22 mars 2024 · The risks set forth above are not exhaustive and additional factors, including those identified in this Annual Report on Form 10-K under the heading “Risk Factors,” for reasons described elsewhere in this Annual Report on Form 10-K and in other filings Phio Pharmaceuticals Corp. periodically makes with the Securities and Exchange …
WebbFind real-time PHIO - Phio Pharmaceuticals Corp stock quotes, company profile, news and forecasts from CNN Business. Webb10 apr. 2024 · The Phio Pharmaceuticals Corp. stock price fell by -3.15% on the last day (Monday, 10th Apr 2024) from $5.71 to $5.53.During the last trading day the stock fluctuated 0.90% from a day low at $5.53 to a day high of $5.58.The price has fallen in 7 of the last 10 days and is down by -3.16% for this period. Volume fell on the last day along …
WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune … Webb30 mars 2024 · With Phio Pharmaceuticals stock trading at $5.83 per share, the total value of Phio Pharmaceuticals stock (market capitalization) is $6.71M. Phio Pharmaceuticals stock was originally listed at a price of $257,400.10 in May 10, 2012. If you had invested in Phio Pharmaceuticals stock at $257,400.10, your return over the last 10 years would …
Webb7 nov. 2024 · /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its... PhioPharma @phio_pharma · May 3, 2024 Phio to present PH-894 data at #ASGCT22 from May 16 - 19th and a trial in progress poster for PH-762 at #ASCO22 from Jun 3 - 7th.
WebbFör 1 dag sedan · Phio Pharmaceuticals Corp. (PHIO) Reports Q3 Loss, Lags Revenue Estimates 11/10/22-5:25PM EST Zacks What Makes Phio Pharmaceuticals Corp. (PHIO) … improve wordle strategyWebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save … improve wordpress securityWebbThe company’s name was changed to Phio Pharmaceuticals in November of 2024 to reflect its transition from a platform company to one committed to discovering immuno … lithium and water react to make lithiumWebbLegal Name Phio Pharmaceuticals Corp. Stock Symbol NASDAQ:PHIO Company Type For Profit Contact Email [email protected] Phone Number 5083665877 Phio Pharmaceuticals is a biotechnology company developing immuno-oncology therapeutics based on its self-delivering RNAi (sd-rxRNA) therapeutic platform. improve wordpress searchWebb6 apr. 2024 · PHIO PHARMACEUTICALS CORP. : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action PHIO PHARMACEUTICALS CORP. PHIO ... lithium and water lewisWebb28 mars 2024 · Streubesitz. 97,9%. Mehr Finanzkennziffern. Unternehmensprofil. Phio Pharmaceuticals Corp. ist ein Biotechnologieunternehmen. Das Unternehmen konzentriert sich auf die Entwicklung immunonkologischer Therapeutika, die auf seiner selbstabgebenden Ribonukleinsäure-Schnittstelle (RNAi) INTASYL-Therapieplattform … improve wordpress speedWebb1 jan. 2024 · Phio Pharmaceuticals Presents Study Outline Of Its First Clinical Trial With Ph-762 For Advanced Melanoma At The 2024 Asco Annual Meeting May 16, 2024 Reuters Phio Pharmaceuticals Presents New Data Demonstrating PH-894 Enhances Activity Of HER2-CAR-T Cells At Asgct 2024 lithium and white blood cell count